Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$74.01
0.060.08%
À la fermeture: -
$73.91
-0.10-0.14%
Après les heures de négociation: 4:09 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Hologic Inc a un objectif de cours consensus de $81.87, basé sur les évaluations des 19 analystes. Le plus élevé est de $95 attribué par Cowen & Co. le février 2, 2023, et le plus bas est de $69 attribué par Morgan Stanley le juillet 31, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Mizuho, Stephens & Co. et JP Morgan le octobre 23, 2025, octobre 22, 2025 et octobre 22, 2025. Avec un objectif de cours moyen de $77.33 entre Mizuho, Stephens & Co. et JP Morgan, il y a une variation implicite de 4.63% upside pour Hologic Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Mizuho
Stephens & Co.
JP Morgan
Leerink Partners
Evercore ISI Group
1calculé à partir des notes des analystes
Notes d'analystes pour Hologic
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/23/2025 | 5.53% | Mizuho | $70 → $78 | Downgrade | Outperform → Neutral | |||
10/22/2025 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
10/22/2025 | 2.83% | Stephens & Co. | $78 → $76 | Downgrade | Overweight → Equal-Weight | |||
10/22/2025 | 5.53% | JP Morgan | → $78 | Downgrade | Overweight → Neutral | |||
10/21/2025 | 5.53% | Leerink Partners | $70 → $78 | Maintains | Market Perform | |||
10/21/2025 | — | BTIG | — | Reiterates | Neutral → Neutral | |||
10/21/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
10/07/2025 | 5.53% | Evercore ISI Group | $69 → $78 | Upgrade | In-Line → Outperform | |||
09/19/2025 | 21.77% | Argus Research | $80 → $90 | Maintains | Buy | |||
09/18/2025 | 5.53% | Stephens & Co. | $78 → $78 | Reiterates | Overweight → Overweight | |||
08/06/2025 | 17.71% | RBC Capital | $72 → $87 | Upgrade | Sector Perform → Outperform | |||
07/31/2025 | -6.64% | Morgan Stanley | $65 → $69 | Maintains | Equal-Weight | |||
07/31/2025 | -5.29% | UBS | $65 → $70 | Maintains | Neutral | |||
07/16/2025 | -5.29% | Mizuho | $65 → $70 | Maintains | Outperform | |||
07/09/2025 | 8.24% | Citigroup | $60 → $80 | Upgrade | Neutral → Buy | |||
07/08/2025 | -8% | Evercore ISI Group | $62 → $68 | Maintains | In-Line | |||
05/28/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
05/13/2025 | -5.29% | Stephens & Co. | $77 → $70 | Maintains | Overweight | |||
05/05/2025 | -12.06% | Morgan Stanley | $77 → $65 | Maintains | Equal-Weight | |||
05/02/2025 | -5.29% | RBC Capital | $75 → $70 | Maintains | Sector Perform | |||
05/02/2025 | -3.94% | Raymond James | $90 → $71 | Reiterates | Outperform → Outperform | |||
05/02/2025 | -16.11% | Evercore ISI Group | $65 → $62 | Maintains | In-Line | |||
05/02/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
04/08/2025 | 1.47% | RBC Capital | $83 → $75 | Maintains | Sector Perform | |||
03/04/2025 | -5.29% | Citigroup | $80 → $70 | Maintains | Neutral | |||
02/06/2025 | 21.77% | Raymond James | $95 → $90 | Reiterates | Outperform → Outperform | |||
02/06/2025 | 15% | RBC Capital | $88 → $85 | Maintains | Sector Perform | |||
02/06/2025 | -1.23% | Evercore ISI Group | $76 → $73 | Maintains | In-Line | |||
02/06/2025 | 13.65% | Stephens & Co. | $84 → $84 | Reiterates | Overweight → Overweight | |||
02/06/2025 | 1.47% | Leerink Partners | $80 → $75 | Downgrade | Outperform → Market Perform | |||
02/06/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
02/03/2025 | 21.77% | Needham | $90 → $90 | Downgrade | Buy → Hold | |||
01/13/2025 | 10.95% | Morgan Stanley | $84 → $82 | Maintains | Equal-Weight | |||
01/13/2025 | 21.77% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
12/19/2024 | 21.77% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
12/13/2024 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
12/10/2024 | 15% | Jefferies | → $85 | Initiates | → Hold | |||
11/05/2024 | 28.53% | Raymond James | $93 → $95 | Maintains | Outperform | |||
11/05/2024 | 17.71% | Mizuho | $90 → $87 | Maintains | Outperform | |||
11/05/2024 | 21.77% | UBS | $84 → $90 | Maintains | Neutral | |||
11/05/2024 | 20.42% | RBC Capital | $86 → $89 | Maintains | Sector Perform | |||
11/05/2024 | 27.18% | JP Morgan | $92 → $94 | Maintains | Overweight | |||
10/15/2024 | 21.77% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
10/08/2024 | 21.77% | Leerink Partners | $95 → $90 | Maintains | Outperform | |||
10/04/2024 | 21.77% | Mizuho | $85 → $90 | Maintains | Outperform | |||
10/01/2024 | 10.95% | Evercore ISI Group | $78 → $82 | Maintains | In-Line | |||
10/01/2024 | 15% | Citigroup | $95 → $85 | Downgrade | Buy → Neutral | |||
09/17/2024 | 21.77% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
08/16/2024 | 10.95% | RBC Capital | $82 → $82 | Reiterates | Sector Perform → Sector Perform | |||
07/30/2024 | 24.48% | Stephens & Co. | $92 → $92 | Reiterates | Overweight → Overweight | |||
07/30/2024 | 5.53% | Evercore ISI Group | $76 → $78 | Maintains | In-Line | |||
07/30/2024 | 28.53% | JP Morgan | $91 → $95 | Maintains | Overweight | |||
07/30/2024 | 10.95% | RBC Capital | $81 → $82 | Maintains | Sector Perform | |||
07/30/2024 | 21.77% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
07/02/2024 | 2.83% | Evercore ISI Group | $78 → $76 | Maintains | In-Line | |||
06/27/2024 | 17.71% | Stephens & Co. | → $87 | Initiates | → Overweight | |||
05/09/2024 | 28.53% | Argus Research | $89 → $95 | Maintains | Buy | |||
05/03/2024 | 21.77% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
05/03/2024 | 23.12% | JP Morgan | $85 → $91 | Maintains | Overweight | |||
04/10/2024 | 21.77% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
04/04/2024 | 5.53% | Evercore ISI Group | $76 → $78 | Maintains | In-Line | |||
04/03/2024 | 28.53% | Citigroup | $80 → $95 | Upgrade | Neutral → Buy | |||
02/02/2024 | 19.06% | Raymond James | $85 → $88 | Maintains | Outperform | |||
02/02/2024 | 6.89% | UBS | $78 → $79 | Maintains | Neutral | |||
02/02/2024 | 21.77% | Needham | $83 → $90 | Maintains | Buy | |||
11/16/2023 | 5.53% | UBS | $91 → $78 | Maintains | Neutral | |||
11/13/2023 | 10.95% | Morgan Stanley | $86 → $82 | Maintains | Equal-Weight | |||
11/10/2023 | -2.58% | RBC Capital | $74 → $72 | Maintains | Sector Perform | |||
10/26/2023 | 12.3% | Needham | $95 → $83 | Maintains | Buy | |||
10/18/2023 | 15% | Raymond James | $95 → $85 | Maintains | Outperform | |||
10/05/2023 | 4.18% | RBC Capital | $81 → $77 | Maintains | Sector Perform | |||
08/01/2023 | 28.53% | Needham | $95 → $95 | Reiterates | Buy → Buy | |||
08/01/2023 | 16.36% | Morgan Stanley | $86 → $86 | Reiterates | Equal-Weight → Equal-Weight | |||
08/01/2023 | 15% | Citigroup | $90 → $85 | Maintains | Neutral | |||
08/01/2023 | 15% | RBC Capital | $87 → $85 | Maintains | Sector Perform | |||
08/01/2023 | 16.36% | B of A Securities | $94 → $86 | Maintains | Neutral | |||
08/01/2023 | 28.53% | Raymond James | $100 → $95 | Maintains | Outperform | |||
07/14/2023 | 28.53% | Needham | → $95 | Upgrade | Hold → Buy | |||
06/15/2023 | 28.53% | Mizuho | → $95 | Reiterates | Buy → Buy | |||
05/03/2023 | 16.36% | Morgan Stanley | $81 → $86 | Maintains | Equal-Weight | |||
05/02/2023 | 17.71% | RBC Capital | → $87 | Reiterates | → Sector Perform | |||
05/02/2023 | 42.06% | JP Morgan | $95 → $105 | Maintains | Overweight | |||
05/02/2023 | 15% | Wells Fargo | $80 → $85 | Maintains | Equal-Weight | |||
05/02/2023 | 35.3% | Raymond James | $95 → $100 | Maintains | Outperform | |||
05/02/2023 | 28.53% | Mizuho | $92 → $95 | Maintains | Buy | |||
05/02/2023 | 21.77% | Citigroup | $85 → $90 | Maintains | Neutral | |||
04/18/2023 | 24.48% | Mizuho | $90 → $92 | Maintains | Buy | |||
02/03/2023 | 9.59% | Morgan Stanley | $74 → $81 | Maintains | Equal-Weight | |||
02/02/2023 | 28.53% | Cowen & Co. | $86 → $95 | Maintains | Outperform | |||
02/02/2023 | 28.53% | JP Morgan | $90 → $95 | Maintains | Overweight | |||
02/02/2023 | 15% | Citigroup | $75 → $85 | Maintains | Neutral | |||
02/02/2023 | 28.53% | Raymond James | $80 → $95 | Maintains | Outperform | |||
02/02/2023 | 25.83% | SVB Leerink | $90 → $93 | Maintains | Outperform | |||
01/24/2023 | 21.77% | Mizuho | $77 → $90 | Maintains | Buy | |||
01/12/2023 | 21.77% | SVB Leerink | $85 → $90 | Maintains | Outperform | |||
01/10/2023 | 8.24% | Wells Fargo | $75 → $80 | Maintains | Equal-Weight | |||
01/06/2023 | 15% | SVB Leerink | $78 → $85 | Maintains | Outperform | |||
12/07/2022 | 1.47% | RBC Capital | → $75 | Initiates | → Sector Perform | |||
11/01/2022 | -5.29% | Evercore ISI Group | $65 → $70 | Maintains | In-Line | |||
11/01/2022 | 16.36% | Cowen & Co. | $88 → $86 | Maintains | Outperform |
FAQ
Quel est le cours indicatif de l'action Hologic (HOLX) ?
Le dernier objectif de prix pour Hologic (NASDAQ:HOLX) a été rapporté par Mizuho le octobre 23, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $78.00 s'attendant à ce que HOLX se rise dans les 12 prochains mois (un possible changement de 5.53% upside). 42 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Hologic (HOLX) ?
La dernière note d'analyste pour Hologic (NASDAQ:HOLX) a été fournie par Mizuho, et Hologic réduit leur note neutral.
Quand a eu lieu la dernière mise à niveau pour Hologic (HOLX) ?
La dernière amélioration pour Hologic Inc a eu lieu le octobre 7, 2025 lorsque Evercore ISI Group a augmenté leur objectif de prix à $78. Evercore ISI Group avait précédemment an in-line pour Hologic Inc.
Quand a eu lieu la dernière dégradation pour Hologic (HOLX) ?
La dernière réduction pour Hologic Inc a eu lieu le octobre 23, 2025 lorsque Mizuho a changé leur objectif de prix de $70 à $78 pour Hologic Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Hologic (HOLX) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Hologic, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Hologic a été déposée le octobre 23, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 23, 2026.
La note d'analyste pour Hologic (HOLX) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Hologic (HOLX) était un réduit avec un objectif de prix de $70.00 à $78.00. Le prix actuel de Hologic (HOLX) est de $73.91, ce qui est within la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.